|1.||Uchida, Yoko: 5 articles (10/2009 - 08/2002)|
|2.||Hozumi, Isao: 4 articles (01/2013 - 03/2006)|
|3.||Satoh, Masahiko: 3 articles (11/2012 - 10/2009)|
|4.||Hara, Hideaki: 3 articles (11/2012 - 10/2009)|
|5.||Honda, Akiko: 3 articles (11/2012 - 10/2009)|
|6.||Inuzuka, Takashi: 3 articles (10/2010 - 03/2006)|
|7.||Hwang, Yong Pil: 3 articles (12/2009 - 05/2008)|
|8.||Jeong, Hye Gwang: 3 articles (12/2009 - 05/2008)|
|9.||Kim, Hyung Gyun: 3 articles (12/2009 - 05/2008)|
|10.||Miyazaki, I: 3 articles (02/2001 - 01/2000)|
|1.||Wounds and Injuries (Trauma)
12/05/2001 - "Different protective roles in vitro of alpha- and beta-domains of growth inhibitory factor (GIF) on neuron injuries caused by oxygen free radicals."
01/01/2001 - "Metallothioneins-I+II are antioxidant proteins induced in the CNS by immobilisation stress, trauma or degenerative diseases which have been postulated to play a neuroprotective role, while the CNS isoform metallothionein-III has been related to Alzheimer's disease. "
09/01/2010 - "Here we show that: (1) Zn(2+) is released intracellularly after oxidant and SD injuries, and that sensitivity to these injuries is proportional to neuronal Zn(2+) content; (2) NAD(+) loss is involved - restoration of NAD(+) using exogenous NAD(+) , pyruvate or nicotinamide attenuated these injuries, and potentiation of NAD(+) loss potentiated injury; (3) neurons from genetically modified mouse strains which reduce intracellular Zn(2+) content (MT-III knockout), reduce NAD(+) catabolism (PARP-1 knockout) or increase expression of an NAD(+) synthetic enzyme (Wld(s) ) each had attenuated SD and oxidant neurotoxicities; (4) sirtuin inhibitors attenuated and sirtuin activators potentiated these neurotoxicities; (5) visual cortex ablation (VCA) induces Zn(2+) staining and death only in ipsilateral LGNd neurons, and a 1 mg/kg Zn(2+) diet attenuated injury; and finally (6) NAD(+) synthesis and levels are involved given that LGNd neuronal death after VCA was dramatically reduced in Wld(s) animals, and by intraperitoneal pyruvate or nicotinamide. "
02/01/2015 - "Phosphoserine dimers (2PS) reduced IL-8 secretion in H2 O2 -treated Caco-2 cells, and reduced H2 O2 -induced expression of genes involved in inflammation and generation of reactive oxygen species (ROS), including chemokine (C-C motif) ligand 5 (CCL5), lactoperoxidase (LPO), myeloperoxidase (MPO), neutrophil cytosolic factor 1/2 (NCF1/2), and nitric oxide synthase 2A (NOS2), and upregulated metallothionein 3 (MT3), peroxiredoxin 3 (PRDX3), and surfactant, pulmonary-associated protein D (SFTPD), which are involved in protection against oxidative stress and activation of the Nrf2 signaling pathway. "
01/01/1986 - "Genetic studies on a tumor growth-inhibitory factor in serum of normal mice and its relationship to NK activity."
01/01/2014 - "Metallothionein III (MT3) is a tumor suppresser reported to show promoter hypermethylated in various cancers. "
03/01/2013 - "MT-III expression was noted in the cytoplasm and nucleus of cancer cells. "
09/01/1994 - "We conclude that BBS is a growth inhibitory factor for H2T tumors and that different mechanisms may be responsible for the differential growth effects elicited by normal and neoplastic pancreas in response to BBS."
01/01/1993 - "We also found that the tumor growth inhibitory factor (TGIF) activity was produced in the culture supernatant (CSN) of the OK-432-activated PBMC (OK-MC) and the activity synchronously increased with augmentation of OKAK activity. "
|4.||Alzheimer Disease (Alzheimer's Disease)
07/15/2015 - "Virtual screening, ADMET profiling, molecular docking and dynamics approaches to search for potent selective natural molecules based inhibitors against metallothionein-III to study Alzheimer's disease."
12/01/1992 - "In previous studies, we discovered a growth inhibitory factor (GIF) that was abundant in normal human brain, but greatly reduced in Alzheimer's disease (AD) brain. "
07/15/2015 - "An altered expression level of MT-III suggests that it could be a mitigating factor in Alzheimer's disease (AD) neuronal dysfunction. "
01/01/2014 - "In general, MT-1 and MT-2 induce cell growth and differentiation, whereas MT-3 is a growth inhibitory factor, which is reduced in Alzheimer's disease. "
02/01/2011 - "Metallothionein 3 (MT-3) has been shown to protect against apoptotic neuronal death in the brains of patients with Alzheimer's disease. "
02/15/1997 - "Conversely, transgenic mice containing elevated levels of MT-III were more resistant to CA3 neuron injury induced by seizures. "
08/01/1996 - "Studies demonstrating that MT-III prevents neuronal sprouting in vitro, appears to be down-regulated in Alzheimer's disease, and that MT-III "knockout" mice appear highly sensitive to kainateinduced seizures have focused growing attention on the etiologic role of MT-III in neurodegeneration.-Aschner, M. "
02/15/1997 - "MT-III-deficient mice were more susceptible to seizures induced by kainic acid and subsequently exhibited greater neuron injury in the CA3 field of hippocampus. "
02/15/1997 - "Disruption of the metallothionein-III gene in mice: analysis of brain zinc, behavior, and neuron vulnerability to metals, aging, and seizures."
02/01/1997 - "Dr. Palmiter discussed the properties of MT-III and the increased sensitivity of MT-III knockout mice to kainate-induced seizures. "
|1.||Reactive Oxygen Species (Oxygen Radicals)
|4.||Pyruvic Acid (Pyruvate)
|5.||Nitric Oxide Synthase (NO Synthase)
|6.||Interleukin-8 (Interleukin 8)
|7.||Pulmonary Surfactants (Pulmonary Surfactant)